Correction to Lancet Rheumatol 2020; 2: e270-80

No authors listed

Published Erratum

No authors listed. Lancet Rheumatol. 2020 Jul.

. 2020 Jul;2(7):e388.

doi: 10.1016/S2665-9913(20)30166-1. Epub 2020 Jun 25.

No abstract available

Erratum for

Dapansutrile, an oral selective NLRP3 inflammasome inhibitor, for treatment of gout flares: an open-label, dose-adaptive, proof-of-concept, phase 2a trial.
Klück V, Jansen TLTA, Janssen M, Comarniceanu A, Efdé M, Tengesdal IW, Schraa K, Cleophas MCP, Scribner CL, Skouras DB, Marchetti C, Dinarello CA, Joosten LAB. Klück V, et al. Lancet Rheumatol. 2020 May;2(5):e270-e280. doi: 10.1016/s2665-9913(20)30065-5. Epub 2020 Apr 8. Lancet Rheumatol. 2020. PMID: 33005902 Free PMC article.